We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Teva Contests 2 Of Gilead’s Truvada Patents

Law360, New York (November 17, 2008, 12:00 AM EST) -- Israel-based Teva Pharmaceutical Industries Inc. is taking steps to gain regulatory approval to market a generic version of Gilead Sciences Inc.’s lucrative HIV medication Truvada and has challenged two of the...
To view the full article, register now.